Can a cholesterol drug calm inflammation in diabetes? new study explores.
Knowledge-focused
Completed
This study looked at how evolocumab (Repatha) affects markers of inflammation and blood clotting in 41 people with type 2 diabetes and heart or blood vessel disease. Participants received either evolocumab or a placebo injection every 4 weeks for 3 doses. The goal was to understa…
Phase: PHASE4 • Sponsor: Robert Rosenson • Aim: Knowledge-focused
Last updated May 01, 2026 15:59 UTC